• About us
  • People
  • Expertise
    • Sectors
        • Technology, media & communications Technology, media & communications
        • Private Wealth Private wealth
        • Real estate, infrastructure & energy
        • Life sciences & healthcare icon Life sciences & healthcare
        • Aerospace & defence
        • Automotive & mobility
        • Business & professional services
        • Chemicals
        • Consumer & retail
        • Financial institutions & insurance
        • Hotels, hospitality & leisure
        • Logistics & transport
        • Manufacturing & industrials
        • Public services & education
    • Legal services
        • Artificial intelligence
        • Banking & finance
        • Brands & advertising
        • Commercial & consumer contracts
        • Competition, EU & trade
        • Copyright & media law
        • Corporate crime & compliance
        • Corporate/M&A & capital markets
        • Data & cyber
        • Disputes & investigations
        • Employment, pensions & mobility
        • Environmental, planning & regulatory
        • Environmental, social & governance (ESG)
        • Intellectual property
        • Information technology
        • Patents & innovation
        • Private client
        • Private equity
        • Projects, energy & infrastructure
        • Real estate & construction
        • Regulation
        • Restructuring & insolvency
        • Tax
        • Venture capital
  • Locations
    • Europe
        • Locations
        • Austria
        • Belgium
        • Czech Republic
        • France
        • Germany
        • Hungary
        • Italy
        • Netherlands
        • Poland
        • Portugal
        • Ireland
        • Slovakia
        • Spain
        • United Kingdom
        • Ukraine
          Groups & regions
        • CEE Turkish Desk
        • French German group
        • Our offices
    • Middle East & Africa
        • Locations
        • Middle East
        • UAE
          Groups
        • Africa group
        • Israel group
        • Our offices
    • Americas
        • Locations
        • Latin America
        • USA
          Groups
        • Brazil group
        • Our offices
    • Asia
        • Locations
        • Asia
        • China
        • South Korea
          Groups
        • India group
        • Japan group
        • Our offices
  • Insights
    • Insights
        • Featured Topics
        • Artificial intelligence
        • Data Centre Expertise
        • The EU Whistleblower Directive
        • German Supply Chain Act
        • Unified Patent Court
          Content hub
        • Global Data Hub
        • Interface: tech, IP and media law
        • Podcasts
        • Synapse
        • Browse all insights
    • In focus
        • AI
        • Dealonomics
        • Disputes
        • Intellectual property
        • MENA
        • Regulation
        • Browse in focus
    • Events
        • In person
        • Online
        • Browse all events
    • News
        • Media centre
        • Work highlights
        • Firm news
        • Browse all news
  • Careers
  • EN
    • English
    • 中文(简体)
    • Français
    • Deutsch
  • Home
  • People
  • Andrew Payne
Andrew Payne
Andrew Payne

Andrew Payne

Partner

  • London UK
Contact Me Today
+44 207 300 7145
vCard
Email me Call me
Featured award

Legal 500

Intellectual Property: patents (contentious & non-contentious) - "Andrew has been identified as a key name to note."

Scroll to featured award

Andrew is a partner in the Patents & Innovation team and offers expert counsel on contentious patent and regulatory matters.

Leveraging his previous experience as a medicinal chemist in the pharmaceutical industry, he is particularly focused on advising companies within the life sciences sector and is recognised by clients for his extensive industry knowledge.

Expertise

Services and Groups

Patents & innovation
Commercial & consumer contracts
Disputes & investigations
Resolving patents & know-how disputes
Advising on life sciences regulation
Drafting and negotiating patents & know-how commercial agreements
IP disputes
Commercial disputes

Sectors

Life sciences & healthcare
Chemicals
Manufacturing & industrials
Biotech
Medical devices
Life sciences start-ups and investors
Pharmaceuticals

CV

Since 2025 Partner, Taylor Wessing
2024 - 2025 Senior Counsel, Taylor Wessing
2020 - 2024 Senior Associate, Taylor Wessing
2015 - 2020 Associate, Taylor Wessing
2013 - 2015 Trainee Solicitor , CMS Cameron McKenna
2009 - 2013 Group Leader, Medicinal Chemistry at Eisai
2000 - 2009 Team Leader, GlaxoSmithKline
1998 - 1999 Postdoctoral Researcher, The University of Texas at Austin
2015 Admitted as a lawyer, England & Wales
2013 LPC distinction, BPP Law School
2011 GDL commendation, BPP Law School, London
1997 PhD in synthetic organic chemistry from Imperial College, London
1994 BSc Hons Chemistry, Imperial College and Università degli Studi di Firenze, Italy

Career

Since 2025 Partner, Taylor Wessing
2024 - 2025 Senior Counsel, Taylor Wessing
2020 - 2024 Senior Associate, Taylor Wessing
2015 - 2020 Associate, Taylor Wessing
2013 - 2015 Trainee Solicitor , CMS Cameron McKenna
2009 - 2013 Group Leader, Medicinal Chemistry at Eisai
2000 - 2009 Team Leader, GlaxoSmithKline
1998 - 1999 Postdoctoral Researcher, The University of Texas at Austin

Education

2015 Admitted as a lawyer, England & Wales
2013 LPC distinction, BPP Law School
2011 GDL commendation, BPP Law School, London
1997 PhD in synthetic organic chemistry from Imperial College, London
1994 BSc Hons Chemistry, Imperial College and Università degli Studi di Firenze, Italy

Publications

Declaratory Relief in the English Patents Court, Bio-Science Law Review, 2016, p 123-128
Patents Overhauled: Impact of the America Invents Act on the Pharmaceutical Industry (co-author), European Biopharmaceutical Review, Spring 2015
New and Approved: The New EU Clinical Trials Regulation (co-author), European Pharmaceutical Contractor, December 2014 p 50-53

Additional languages

Italian Spanish

Awards

Legal 500

Featured

Intellectual Property: patents (contentious & non-contentious) - "Andrew has been identified as a key name to note."

Andrew's news & insights

View Andrew's insights
UPC
Click here to find out more
UPC

The UK and the Unified Patent Court, two years in - how can long-arm reach be prevented in the UK?

4 June 2025

by Dr Paul England and Andrew Payne

Glass.Mapper.Sc.Fields.Image?.Alt
Patents & innovation

Dealing with difficult service in the UPC: The cases of Philips IP Ventures v Belkin and Panasonic v Xiaomi as examples.

24 January 2024
In-depth analysis

by multiple authors

Click here to find out more
Glass.Mapper.Sc.Fields.Image?.Alt
Life sciences & healthcare

Brexit and beyond – Wellcome's recommendations from the Future Partnership Project

30 March 2018
Briefing

by Andrew Payne

Click here to find out more
View Andrew's insights

Related news & insights

Update from Berlin: Federal government tightens cannabis policy

8 January 2026
Briefing

by Kathleen Munstermann-Senff, LL.M. (Medical Law) and Dr. Martin Jäger

Click here to find out more
Netherlands

Partner appointment Margot van Gerwen

5 January 2026

by Margot van Gerwen

Click here to find out more
Lights on network server
Life sciences & healthcare

Data Provision under the Data Act in the Life Sciences Environment

5 January 2026
In-depth analysis

by Dr. Julia Freifrau von Imhoff and Dr. Christian Frank, Licencié en droit (Paris II / Panthéon-Assas)

Click here to find out more
Close up of a walnut
Life sciences & healthcare

EUDAMED-Rollout: From a Perpetual Construction Site to Regulatory Reality

5 January 2026
In-depth analysis

by Irina Rebin

Click here to find out more
Data centre server room
Life sciences & healthcare

Everything Is Relative? Implications of the CJEU Judgment C-413/23 (SRB/EDPS) for the Secondary Use of Personal Data in Research Practice

5 January 2026
In-depth analysis

by Stephanie Richter, LL.M. (Torino), CIPP/E

Click here to find out more
Paper craft brain
Life sciences & healthcare

The European Innovation Act: From Regulatory Fragmentation to Coherent Innovation Governance

5 January 2026
In-depth analysis

by Irina Rebin

Click here to find out more
office at night
Corporate/M&A & capital markets

Taylor Wessing advises Andreessen Horowitz and Index Ventures on US$41 million seed financing of Mirelo AI

23 December 2025

by multiple authors

Click here to find out more
Close-Up Of Shopping Cart
Commercial & consumer contracts

Product safety for consumer products: New EU guidelines from November 2025

22 December 2025
Briefing

by Dr. Benedikt Rohrßen and Dr. Ulrich Spiegel

Click here to find out more
Close up of a walnut on grey background
UPC

Pre-trial discovery before the UPC? – Pharmaceuticals, Trade fairs and beyond

19 December 2025
In-depth analysis

by multiple authors

Click here to find out more
Tunnel with vanishing point and neon lights
Disputes & investigations

When the evidence thinks for itself: how will the courts keep AI-generated evidence in check?

12 December 2025
Briefing

by Helen Robinson and Andrew Spencer

Click here to find out more
View all insights

Related people

UK
Global
Alexander Walker

Alexander Walker

Associate

London
+44 20 7300 7000
Email me
View profile
Dr Katie Atkinson

Dr Katie Atkinson

Senior Associate

London
+44 20 7300 7000
Email me
View profile
Paolo Palmigiano

Paolo Palmigiano

Partner

London
Brussels
+44 20 7300 4138
Email me
View profile
Alison Dennis

Alison Dennis

Partner

London
+44 20 7300 4725
Email me
View profile
Sarah Parkin

Sarah Nesbitt

Senior Associate

London
+44 20 7300 7000
Email me
View profile
Zachary Tan

Zachary Tan

Senior Associate

London
+44 20 7300 7000
Email me
View profile
Curtis Anderson

Curtis Anderson

Associate

London
+44 20 7300 7000
Email me
View profile
Stephanie High

Stephanie High

Senior Associate

London
+44 20 7300 7000
Email me
View profile
Nigel Stoate

Nigel Stoate

Partner

London
+44 20 7300 4783
Email me
View profile
Charlie Adams

Charlie Adams

Senior Counsel

Cambridge
+44 1223 446 400
Email me
View profile
Full team
Tim Wünnemann

Dr. Tim Wünnemann

Partner

Berlin
+49 30 885636 0
Email me
View profile
Charlie Adams

Charlie Adams

Senior Counsel

Cambridge
+44 1223 446 400
Email me
View profile
Boris Smit

Boris Smit

Associate

Amsterdam
+31 88 024 3272
Email me
View profile
Yolandi Coetzee

Yolandi Coetzee

Patent Attorney

Eindhoven
+31 88 02 43 124
Email me
View profile
Sally Annereau

Sally Annereau

Senior Adviser

London
+44 20 7300 7000
Email me
View profile
Nigel Stoate

Nigel Stoate

Partner

London
+44 20 7300 4783
Email me
View profile
Joris ter Beek

Joris ter Beek

Associate

Eindhoven
+31 88 02 43 140
Email me
View profile
Charlotte Posthuma

Charlotte Posthuma

Partner

Eindhoven
Amsterdam
+31 88 02 43 044
Email me
View profile
Claudia Vander Velde

Claudia Vander Velde

Trainee Patent Attorney

Brussels
+32 472 28 89 06
Email me
View profile

Jo Joyce

Partner

Dublin
+353 87 787 0901
Email me
View profile
Full team

Meet me at

There are no upcoming events

See all events
Subscribe to our latest insights
  • About us
  • Campaigns and online tools
  • News
  • People
  • Expertise
  • Locations
  • Insights
  • Events
  • Media centre
  • Contact
  • Careers
  • Alumni
  • Data protection & privacy policy
  • Cookie policy
  • Legal and regulatory information
  • Regulatory information on costs
  • Complaints procedure for clients
  • Terms of use
  • Anti-slavery statement
  • Environmental
  • Scam emails

© Taylor Wessing